H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: SKB BIO(06990) the Revenue is 1.129 B (+8.54%), Miss estimate;the EBIT is -579.41 M (-159.1%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
1.13B8.54%
1.55B48.58%
-0.42B40.04%
EBITMiss expectations
-0.58B159.09%
0.13B158.32%
-0.71B317.41%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf